Yinghua "Winston' Mei Comment On Regulatory Notice 22-08
Yinghua "Winston' Mei
none
As an individual investor, I will OBJECT too much regulatory requirements on investors. It will NOT protect small investors, instead of creates confusion and overhead (which will be added to investors in some way). Most stocks aren't less risky than leveraged and inverse funds are.
Any proposal that testing specialized investment knowledge, demonstrate a high net worth and go though a cooling off period will just sound great, but in real world, it is NOT to do any help to investor..
The BEST a regulator can do on this subjects are ask Complex Products to publish transparent prospects. I found many prospects is 'hiding' important facts of risk in their lengthy papers and diluting real principle information.
For the Public
FINRA DATA
FINRA Data provides non-commercial use of data, specifically the ability to save data views and create and manage a Bond Watchlist.
For Industry Professionals
FINPRO
Registered representatives can fulfill Continuing Education requirements, view their industry CRD record and perform other compliance tasks.
For Member Firms
FINRA GATEWAY
Firm compliance professionals can access filings and requests, run reports and submit support tickets.
For Case Participants
DR PORTAL
Arbitration and mediation case participants and FINRA neutrals can view case information and submit documents through this Dispute Resolution Portal.
Need Help? | Check System Status
Log In to other FINRA systems
Yinghua "Winston' Mei Comment On Regulatory Notice 22-08
As an individual investor, I will OBJECT too much regulatory requirements on investors. It will NOT protect small investors, instead of creates confusion and overhead (which will be added to investors in some way). Most stocks aren't less risky than leveraged and inverse funds are.
Any proposal that testing specialized investment knowledge, demonstrate a high net worth and go though a cooling off period will just sound great, but in real world, it is NOT to do any help to investor..
The BEST a regulator can do on this subjects are ask Complex Products to publish transparent prospects. I found many prospects is 'hiding' important facts of risk in their lengthy papers and diluting real principle information.